[Skip to Navigation]
Sign In
Recommendation Statement
April 27, 2021

The USPSTF Recommendation on Blood Pressure Screening: Making 2021 the Transformative Year in Controlling Hypertension

Author Affiliations
  • 1Columbia University Irving Medical Center, New York, New York
  • 2University of Alabama at Birmingham
  • 3UT Southwestern, Dallas, Texas
JAMA. 2021;325(16):1618-1619. doi:10.1001/jama.2021.4499

The year 2020 will be remembered as a time when COVID-19 disrupted all aspects of life, including medicine. As of mid-March, 2021, more than 500 000 people in the US and 2.6 million worldwide have died of COVID-19. Despite its morbidity and mortality, the COVID-19 pandemic also has spurred a remarkably rapid rethinking of how scientific research is conducted and how health care is delivered. Within 1 year, multiple diagnostic tests, medications, and vaccines were developed, tested, and disseminated. More than 100 million people in the US have been screened for COVID-19, and an ongoing vaccination campaign is designed to achieve herd immunity in the near future. These successes required the combined dedicated effort of scientists, health care workers, industry partners, politicians, and the population at large. Looking past COVID-19, the US needs to consider how to apply similar urgency and ingenuity to address other important health care crises, including hypertension—a risk factor that contributes to more than 500 000 deaths annually in the US and 7.8 million deaths worldwide.1,2

Add or change institution